Esomeprazole and omeprazole may increase the serum concentrations of benzodiazepines (via CYP2C19 inhibition) leading to enhanced adverse effects such as drowsiness, although the clinical relevance is minimal in many individuals – check the individual for adverse effects (e.If affected individual are not able to resume their usual oral medication